SAI LIFE SCIENCES LIMITED (SAILIFE) Share Price Hits 52-Week High

SAI LIFE SCIENCES LIMITED Share Price reached a fresh 52-week high at Rs 1,340.3, rising 1.84% today with a market cap of Rs 27,940.13 crore.

SAI LIFE SCIENCES LIMITED Share Price has surged to a fresh 52-week high, reaching Rs 1,340.3, marking a 1.84% increase from the previous close of Rs 1,316.1. The company's market capitalisation now stands at Rs 27,940.13 crore. This milestone highlights the stock's strong performance in the market, drawing attention from investors and analysts alike. The rise in share price is noteworthy, given the company's position in the healthcare sector, which has been experiencing varied trends.

SAI LIFE SCIENCES LIMITED Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 1,340.3
Previous Close	Rs 1,316.1
Today's Change	+Rs 24.2 (+1.84%)
Day Open	Rs 1,318.25
Fresh 52-Week High	Rs 1,348
Day Low	Rs 1,318
Current Volume	11,067
Turnover	Rs 1.48 crore
Market Capitalisation	Rs 27,940.13 crore

SAI LIFE SCIENCES LIMITED (SAILIFE) traded at Rs 1,340.3. versus the previous close of Rs 1,316.1, a rise of 1.84%. The stock opened at Rs 1,318.25, reached Rs 1,348, touched Rs 1,318. Reported volume was 11,067.

Today, SAI LIFE SCIENCES LIMITED opened at Rs 1,318.25 and reached a high of Rs 1,348, setting a new 52-week peak. The stock's low for the day was Rs 1,318, with a turnover of Rs 1.48 crore and a trading volume of 11,067 shares. The 1.84% increase in share price from the previous close indicates positive market sentiment. This upward movement in price action suggests growing investor interest, potentially driven by broader sector trends or market dynamics.

SAI LIFE SCIENCES LIMITED (SAILIFE) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 27,940.13 crore
P/E Ratio	30.09x
P/B Ratio	0.44x
ROE	-2.89%
ROCE	-0.26%

SAI LIFE SCIENCES LIMITED was valued at a P/E ratio of 30.09x, a P/B ratio of 0.44x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of -2.89% and ROCE of -0.26%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Benchmark Scope	same sector
Company P/E Ratio	30.09x
Benchmark Median P/E	20.73x
Benchmark Average P/E	67.98x
Benchmark P/E Range	0x to 3,417.8x
Company P/B Ratio	0.44x
Benchmark Median P/B	1.91x
Company ROE	-2.89%
Benchmark Median ROE	10.7%
Company ROCE	-0.26%
Benchmark Median ROCE	13.13%
Company Market Capitalisation	Rs 27,940.13 crore
Benchmark Median Market Cap	Rs 130.49 crore

SAI LIFE SCIENCES LIMITED (SAILIFE) is classified under sector: Healthcare.

SAI LIFE SCIENCES LIMITED (SAILIFE) has a P/E ratio of 30.09x, which is above the benchmark median of 20.73x, a difference of +45.15%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

SAI LIFE SCIENCES LIMITED (SAILIFE) has a ROE of -2.89%, which is below the benchmark median of 10.7%, a difference of -127.01%. SAI LIFE SCIENCES LIMITED (SAILIFE) has a ROCE of -0.26%, which is below the benchmark median of 13.13%, a difference of -101.98%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Dishman Carbogen Amcis Ltd.	DCAL	2,931.84	30.09	0.44	-2.89	-0.26
Kwality Pharmaceuticals Ltd.	KPL	2,683.28	39.84	8.11	28.21	26.35
Beta Drugs Ltd.	BETA	2,474.26	59.65	7.97	18.65	22.17
Sai Parenteral's Ltd.	SAIPARENT	2,416.82	169.49	3.13	13.9	12.97
Dr Agarwals Eye Hospital Ltd.	DRAGARWQ	2,414	34.44	6.97	-2.6	16.92

SAI LIFE SCIENCES LIMITED (SAILIFE) has a P/E ratio of 30.09x compared with the displayed peer median of 39.84x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -2.89% compares with a peer median of 13.9% across the companies shown in the table. ROCE stood at -0.26% versus the displayed peer median of 16.92%, providing a capital-efficiency comparison. SAI LIFE SCIENCES LIMITED (SAILIFE) has a market capitalisation of Rs 27,940.13 crore. Among the 5 peers shown, 0 have a larger market capitalisation.

Why Investors Are Watching SAI LIFE SCIENCES LIMITED

• SAI LIFE SCIENCES LIMITED Share Price reached a fresh 52-week high, indicating strong market interest.
• Fundamental analysis shows a mixed valuation with a low P/B ratio.
• Sector analysis highlights its significant market cap within healthcare.
• Peer comparison reveals competitive positioning in valuation metrics.

About SAI LIFE SCIENCES LIMITED

SAI LIFE SCIENCES LIMITED operates in the healthcare sector, focusing on pharmaceutical and drug development. The company is involved in various stages of drug discovery and development, catering to both domestic and international markets. Its operations are supported by a robust infrastructure and a commitment to innovation, positioning it as a key player in the healthcare industry. Despite challenges in profitability, the company's scale and market presence remain significant.

Track SAI LIFE SCIENCES LIMITED Share Price on Univest

Use SAI LIFE SCIENCES LIMITED (SAILIFE) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Investors can track SAI LIFE SCIENCES LIMITED Share Price, technical indicators, fundamental ratios, shareholding patterns, and market insights on Univest. This platform provides comprehensive data to support informed investment decisions.

Frequently Asked Questions

What is the current share price of SAI LIFE SCIENCES LIMITED?

Ans. The current share price of SAI LIFE SCIENCES LIMITED is Rs 1,340.3, marking a 1.84% increase from the previous close. The stock moved 1.84% during the session. The intraday range extended from Rs 1,318 to Rs 1,348.

What is the market capitalisation of SAI LIFE SCIENCES LIMITED?

Ans. SAI LIFE SCIENCES LIMITED has a market capitalisation of Rs 27,940.13 crore, significantly above the healthcare sector's median. The company operates in the Healthcare sector. Its P/E ratio is 30.09x.

How does SAI LIFE SCIENCES LIMITED's P/E ratio compare to the sector?

Ans. SAI LIFE SCIENCES LIMITED's P/E ratio of 30.09 is above the sector median of 20.73 but below the average of 67.98. The company trades at a P/E ratio of 30.09x.

What is the P/B ratio of SAI LIFE SCIENCES LIMITED?

Ans. The P/B ratio of SAI LIFE SCIENCES LIMITED is 0.44, indicating a potentially undervalued position relative to its book value. The company trades at a P/E ratio of 30.09x. Its P/B ratio is 0.44x.

How does SAI LIFE SCIENCES LIMITED's market cap compare to its peers?

Ans. SAI LIFE SCIENCES LIMITED's market cap of Rs 27,940.13 crore is significantly higher than its peers, highlighting its larger scale. The company operates in the Healthcare sector. Its P/E ratio is 30.09x.

What is the ROE of SAI LIFE SCIENCES LIMITED?

Ans. SAI LIFE SCIENCES LIMITED has a negative ROE of -2.89%, which may raise concerns about profitability. ROE stands at -2.89%. ROCE stands at -0.26%. The relevant peer median ROE is 10.7%.

What is the 52-week high of SAI LIFE SCIENCES LIMITED?

Ans. The 52-week high of SAI LIFE SCIENCES LIMITED is Rs 1,348, achieved today. The stock moved 1.84% during the session. The intraday range extended from Rs 1,318 to Rs 1,348.

How does SAI LIFE SCIENCES LIMITED's ROCE compare to the sector?

Ans. SAI LIFE SCIENCES LIMITED's ROCE is -0.26%, which is below the sector median of 13.13%. ROE stands at -2.89%. ROCE stands at -0.26%. The relevant peer median ROE is 10.7%.